Zogenix Inc Receivables Turnover Ratio (ZGNX), from the fourth quarter 2021 to the fourth quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zogenix Inc   (NASDAQ: ZGNX)
 

Zogenix Inc Accounts Receivables Turnover Ratio from the fourth quarter 2021 to the fourth quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Zogenix Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2021 to a ratio of 9.77, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2021. Average receivable collection period, for the Zogenix Inc in Dec 31 2021 quarter, has decreased to 37 days, compared to 39 days, in the Sep 30 2021 quarter.

If we take a look into Healthcare sector 183 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2021 from 1477 to 1707.

What is Receivable Turnover Ratio?
What is Zogenix Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZGNX Receivables Turnover Ratio (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Receivable Change 165.14 % 624.68 % - -69 % -
Y / Y Revenue Change 212.95 % 690.56 % 1720.64 % 1157.72 % 336.22 %
Receivable Turnover Ratio (TTM) 9.77 9.37 9.25 9.27 2.17
ZGNX's Total Ranking # 1707 # 1477 # 1531 # 1471 # 1452
Accounts Receivable average collection period days 37 39 39 39 168
Seq. Receivable Change 6.88 % 23.16 % 25.87 % 60.02 % 192.13 %
Seq. Revenue Change 17.68 % 20.34 % 37.31 % 60.95 % 197.27 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 184
Overall Market # 1707

Receivable Turnover Ratio Statistics
High Average Low
21.17 6.82 2.45
(Sep 30 2020)   (Mar 31 2019)





ZGNX Company Profile • Back to ZGNX Efficiency Comparisons • Compare ZGNX Receivables Turnover Ratio to its Competitors

Financial Statements
Zogenix Inc 's Accounts Receivable $ 10 Millions Visit ZGNX's Balance sheet
Zogenix Inc 's Sales TTM $ 82 Millions Visit ZGNX's Income Statement
Sources of ZGNX's Revenues Visit ZGNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ZGNX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ZGNX's Growth Rates ZGNX's Roa ZGNX's Inventory Turnover Ratio ZGNX's Dividend Comparisons
ZGNX's Profitability Ratios ZGNX's Roi ZGNX's Asset Turnover Ratio ZGNX's Dividend Growth
ZGNX's Valuation Ratios ZGNX's Roe ZGNX's Financial Strength Ratios ZGNX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Receivable at quarter ending Dec 31 2021
Zosano Pharma Corporation  21.51 $ 0.785  Millions$ 0.037  Millions
Theralink Technologies Inc   21.44 $ 0.494  Millions$ 0.023  Millions
Sonendo Inc   20.87 $ 33.197  Millions$ 1.591  Millions
Ethema Health Corporation   20.76 $ 1.943  Millions$ 0.094  Millions
Sinovac Biotech Ltd  20.55 $ 19,374.904  Millions$ 942.735  Millions
Caribou Biosciences Inc   20.39 $ 9.598  Millions$ 0.471  Millions
Catheter Precision Inc   20.03 $ 2.133  Millions$ 0.107  Millions
Innovage Holding Corp   19.62 $ 676.344  Millions$ 34.477  Millions
Seer Inc   19.21 $ 6.617  Millions$ 0.345  Millions
Chinook Therapeutics Inc   19.13 $ 51.625  Millions$ 2.699  Millions
Celularity Inc   18.88 $ 21.335  Millions$ 1.130  Millions
Cadre Holdings inc   18.64 $ 427.288  Millions$ 22.922  Millions
Harrow Inc   18.59 $ 72.476  Millions$ 3.898  Millions
Chemed Corporation  17.78 $ 2,149.631  Millions$ 120.872  Millions
Genedx Holdings Corp   17.77 $ 212.195  Millions$ 11.942  Millions
Argenx Se  17.72 $ 497.277  Millions$ 28.058  Millions
Intellia Therapeutics Inc   17.70 $ 33.053  Millions$ 1.867  Millions
Hqda Elderly Life Network Corp.  17.67 $ 0.908  Millions$ 0.051  Millions
Ideaya Biosciences Inc   17.55 $ 27.941  Millions$ 1.592  Millions
Neurometrix Inc   17.51 $ 8.253  Millions$ 0.471  Millions
Travere Therapeutics Inc   16.79 $ 227.490  Millions$ 13.553  Millions
Myovant Sciences Ltd   16.68 $ 198.010  Millions$ 11.873  Millions
Escalon Medical Corp   16.64 $ 10.536  Millions$ 0.633  Millions
Notable Labs Ltd   16.61 $ 0.768  Millions$ 0.046  Millions
Fresh2 Group Ltd  16.50 $ 2.822  Millions$ 0.171  Millions
Vtv Therapeutics Inc   16.23 $ 4.005  Millions$ 0.247  Millions
Addex Therapeutics Ltd  16.19 $ 2.916  Millions$ 0.180  Millions
Sangamo Therapeutics Inc   16.04 $ 110.701  Millions$ 6.902  Millions
Electrocore Inc   15.61 $ 5.451  Millions$ 0.349  Millions
Bicycle Therapeutics Plc  15.60 $ 11.697  Millions$ 0.750  Millions

Date modified: 2026-09-08T15:10:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.